Allogene Therapeutics, Inc. (ALLO)
1.69
-0.04
(-2.31%)
USD |
NASDAQ |
Sep 18, 16:00
1.685
0.00 (0.00%)
After-Hours: 20:00
Allogene Therapeutics Market Cap : 583.63M for Sept. 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 583.63M |
| September 17, 2026 | 597.45M |
| September 16, 2026 | 583.63M |
| September 15, 2026 | 593.99M |
| September 14, 2026 | 614.71M |
| September 11, 2026 | 614.71M |
| September 10, 2026 | 607.81M |
| September 09, 2026 | 597.45M |
| September 08, 2026 | 642.34M |
| September 04, 2026 | 680.33M |
| September 03, 2026 | 683.78M |
| September 02, 2026 | 683.78M |
| September 01, 2026 | 685.51M |
| August 31, 2026 | 690.69M |
| August 28, 2026 | 697.60M |
| August 27, 2026 | 721.77M |
| August 26, 2026 | 704.50M |
| August 25, 2026 | 749.40M |
| August 24, 2026 | 701.05M |
| August 21, 2026 | 721.77M |
| August 20, 2026 | 725.23M |
| August 19, 2026 | 770.12M |
| August 18, 2026 | 701.05M |
| August 17, 2026 | 718.32M |
| August 14, 2026 | 707.96M |
| Date | Value |
|---|---|
| August 13, 2026 | 683.78M |
| August 12, 2026 | 714.86M |
| August 11, 2026 | 732.13M |
| August 10, 2026 | 725.23M |
| August 07, 2026 | 492.08M |
| August 06, 2026 | 482.29M |
| August 05, 2026 | 477.39M |
| August 04, 2026 | 465.15M |
| August 03, 2026 | 450.46M |
| July 31, 2026 | 460.25M |
| July 30, 2026 | 482.29M |
| July 29, 2026 | 443.12M |
| July 28, 2026 | 406.40M |
| July 27, 2026 | 428.43M |
| July 24, 2026 | 425.98M |
| July 23, 2026 | 445.57M |
| July 22, 2026 | 455.36M |
| July 21, 2026 | 452.91M |
| July 20, 2026 | 433.32M |
| July 17, 2026 | 438.22M |
| July 16, 2026 | 438.22M |
| July 15, 2026 | 465.15M |
| July 14, 2026 | 452.91M |
| July 13, 2026 | 472.50M |
| July 10, 2026 | 489.63M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cartesian Therapeutics, Inc. | 241.21M |
| Beam Therapeutics, Inc. | 2.576B |
| Kyverna Therapeutics, Inc. | 439.00M |
| Arrowhead Pharmaceuticals, Inc. | 9.383B |
| Oncolytics Biotech, Inc. | 95.97M |
Market Cap Related Metrics
| PS Ratio | 92.63 |
| Price to Book Value | 1.338 |
| Price | 1.69 |
| Earnings Yield | -39.36% |